Copertina

Contribution of Phenotypic Age Acceleration and Body Mass Index to Psoriasis Risk in US Adults

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yun‐Ni Lin, Xiang‐Hui Huang, Yuan‐Li Meng, Juan Liang, Wen‐Qi Zhao, Wen‐Hao Liu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Two‐Year Real‐World Effectiveness of Deucravacitinib 6 mg in Psoriasis: A Single‐Center Analysis Stratified by Body Mass Index or Age in a Japanese Cohort
di: Yuriko Okabe, et al.
Pubblicazione: (2026)

Eczematous Eruption on Hands and Feet After Treatment With Biological Agents for Psoriasis
di: Fen Peng, et al.
Pubblicazione: (2025)

‘Psoriasis Punctata’: An Under‐Recognised Clinical Phenotype of TNF‐Alpha Inhibitor‐Induced Psoriasis
di: Grace Im, et al.
Pubblicazione: (2025)

Association of Cardiometabolic Index in Psoriasis: Evidence From the National Health and Nutrition Examination Survey
di: Hao Ren, et al.
Pubblicazione: (2026)

Automatic evaluation of Nail Psoriasis Severity Index using deep learning algorithm
di: Kyungho Paik, et al.
Pubblicazione: (2024)

Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study
di: Saori Takamura, et al.
Pubblicazione: (2025)

Cardiovascular Risk in Psoriasis Compared With Atopic Dermatitis: The Shizuoka Kokuho Database
di: Kanako Takeda, et al.
Pubblicazione: (2026)

Adult Vulval Psoriasis: Clinical Presentation, Management and Impact on Quality of Life
di: Michelle Wu, et al.
Pubblicazione: (2025)

Evaluating Psoriasis Severity Using the Neutrophil‐to‐Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio: A Systematic Review and Meta‐Analysis
di: Yi‐Hsuan Shen, et al.
Pubblicazione: (2026)

What is Psoriasis?
Pubblicazione: (2025)

Updated Psoriasis Prevalence and Risk Factors in the United States—Insights From the 2023 NHIS
di: Priya Engel, et al.
Pubblicazione: (2025)

Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance
di: Annika Smith, et al.
Pubblicazione: (2025)

Correction to “Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post‐marketing Surveillance”
Pubblicazione: (2025)

A case of hereditary hemorrhagic telangiectasia treated with cryotherapy
di: Su‐Ying Wen, et al.
Pubblicazione: (2024)

Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis
di: Jun Ting Tang, et al.
Pubblicazione: (2025)

The Impacts of Seasonal Factors on Psoriasis
di: Jundan Yang, et al.
Pubblicazione: (2025)

More Active Hair Growth in Human Scalp Psoriasis and Mouse Psoriasis: Evidence for the Same “Switch‐On” of Psoriasis and Hair Growth
di: Chenxingyue Zhang, et al.
Pubblicazione: (2025)

Long‐Term Particulate Matter Exposure and Risk of Psoriasis Incidence, and Short‐Term Exposure and Risk of Exacerbation: A Nationwide Cohort Study
di: Bo Ri Kim, et al.
Pubblicazione: (2026)

Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry
di: Nicholas Manuelpillai, et al.
Pubblicazione: (2024)

Development of a Nomogram Model for Predicting Anxiety Risk in Patients With Hyperhidrosis: A Study Involving 234 Patients
di: Hao Wen, et al.
Pubblicazione: (2025)

Relationships Between Secukinumab Concentrations, Disease Activity, and IL ‐ 17A Levels in Psoriasis: A Cross‐Sectional Observational Study
di: Kouzhu Zhu, et al.
Pubblicazione: (2025)

Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real‐Life Experience From a Tertiary Referral Center
di: Alessandra Chiei Gallo, et al.
Pubblicazione: (2025)

The Impact of Obesity on Response to Secukinumab in Pediatric Plaque Psoriasis: A Real‐World Study
di: Zhaoyang Wang, et al.
Pubblicazione: (2025)

Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis
di: Nicole Kah Mun Yoong, et al.
Pubblicazione: (2025)

TYK2 and IL‐23 Pathway Therapies in Psoriasis: Associations With IL‐6, Tryptophan Metabolism, and Depressive Symptoms
di: Lanmei Lin, et al.
Pubblicazione: (2026)

Population‐Specific HLA Profiles in Generalised Pustular Psoriasis in Sarawak, Malaysia
di: Ingrid Pao Lin Ting, et al.
Pubblicazione: (2026)

Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice
di: Annika Smith, et al.
Pubblicazione: (2025)

Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease—Clinician Knowledge, Practice and Perceptions
di: Annika Smith, et al.
Pubblicazione: (2025)

Body dysmorphic disorder symptoms in patients with melasma
di: Yuan Zhu, et al.
Pubblicazione: (2024)

The Intersection of Inflammatory Skin Diseases and Women’s Reproductive Health: Challenges in Managing Psoriasis and Atopic Dermatitis During Pregnancy and Hormonal Fluctuations
di: Guifang Qin, et al.
Pubblicazione: (2026)

Real‐World Effectiveness and Safety of Biologic Switches in Chinese Patients With Plaque Psoriasis: A Single‐Center Retrospective Study
di: Yu-Ting Gan, et al.
Pubblicazione: (2025)

Psoriasis management tree based on comorbidity
di: Shivkar Amara, et al.
Pubblicazione: (2024)

Clinical Characteristics and Treatment Patterns of Psoriasis in Asia and Switzerland: Results of the Multicentre Global Healthcare Study on Psoriasis (GHSP)
di: Eyan Goh, et al.
Pubblicazione: (2025)

Research situation, hot spots, and global trends of melasma therapy: Bibliometric insights and visual analysis from 2000 to 2023
di: Chenjie Zheng, et al.
Pubblicazione: (2024)

Increased Abnormal Erythrocytes Caused by Spleen Filtration Deficiency Provide a Hypoxic Environment for the Occurrence of Psoriasis
di: Ya Zhao, et al.
Pubblicazione: (2024)

Effectiveness of Biologics on Preventing the Development of Psoriatic Arthritis in Psoriasis Patients: A Systematic Review
di: Kathleen L. Miao, et al.
Pubblicazione: (2026)

Comprehensive Literature Review Evaluating the Use, Safety, and Efficacy of Subcutaneous Methotrexate in the Treatment of Adult Patients With Moderate‐To‐Severe Plaque‐Type Psoriasis
di: Manuelle Viguier, et al.
Pubblicazione: (2025)

A Case of Palmoplantar Psoriasis Successfully Treated With Tapinarof Cream
di: Ayako Hiraishi, et al.
Pubblicazione: (2025)

Spesolimab for Generalized Pustular Psoriasis in the Late Second Trimester of Pregnancy
di: Miyuki Kato, et al.
Pubblicazione: (2026)

Genital Psoriasis in Asians: Impact on Quality of Life and Sexual Health
di: Kim Yao Ong, et al.
Pubblicazione: (2025)